mRNA |
MG-132 |
CTRPv2 |
pan-cancer |
AAC |
0.098 |
0.1 |
mRNA |
tretinoin:navitoclax (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.056 |
0.1 |
mRNA |
WZ8040 |
CTRPv2 |
pan-cancer |
AAC |
-0.062 |
0.1 |
mRNA |
BRD-K34222889 |
CTRPv2 |
pan-cancer |
AAC |
-0.05 |
0.1 |
mRNA |
bid1870 |
gCSI |
pan-cancer |
AAC |
-0.085 |
0.1 |
mRNA |
tanespimycin:gemcitabine (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.051 |
0.1 |
mRNA |
Docetaxel |
gCSI |
pan-cancer |
AAC |
-0.082 |
0.1 |
mRNA |
linifanib |
CTRPv2 |
pan-cancer |
AAC |
-0.056 |
0.1 |
mRNA |
tosedostat |
CTRPv2 |
pan-cancer |
AAC |
-0.057 |
0.1 |
mRNA |
BRD-K79669418 |
CTRPv2 |
pan-cancer |
AAC |
0.081 |
0.1 |